Trial intelligence / Profile preview

Ahah in HIV/AIDS Patients

NCT04770701Phase 4Withdrawn

Start
Sep 2020
Primary completion
Jun 2025
Countries
1
01

Overview

A Phase 4 trial of Ahah in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS). Planned start Sep 2020; status: withdrawn.

02

Drugs

Ahah
03

Conditions

human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)

Beyond the preview

Go deeper on NCT04770701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04770701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call